Infographic: Banking on Biology
Biobanking gives scientists access to thousands of biological samples, moving precision medicine one step closer to reality.
Cancer Research
GENUINE progress
TG Therapeutics' GENUINE trial shows that ublituximab plus ibrutinib improves survival in patients with chronic lymphocytic leukemia
An alliance for drug development
UCLA researchers to select candidates for development with Xencor’s modular XmAb platforms
Bringing down the cost of cancer?
NuView’s theranostics approach could make cancer diagnosis and treatment more affordable
A different kind of TROLL
APIS and Moffitt pair up to assess TROLL lncRNAs as predictive biomarkers in cancer
In pursuit of pancreatic cancer
Study finds combination therapy with NAMPT inhibitors and STING agonists can suppress pancreatic tumor growth in mice
aTyr begins new tRNA programs
aTyr Pharma initiates two new tRNA synthetase discovery programs
FDA approves Libtayo for basal cell carcinoma
Libtayo receives full approval in locally advanced BCC and accelerated approval in metastatic BCC
FDA approves new treatment for NSCLC
FDA approves Tepmetko as a once-daily oral MET inhibitor for NSCLC with METex14 skipping alterations
A feather in CEVEC’s CAP
CARISMA receives full rights for use of CEVEC’s CAP technology in anti-tumor cell therapies
A helping hand from Hemibody
MorphoSys licenses Hemibody technology from Cherry Biolabs in hopes of improving T cell-based therapeutics
